Boston Partners’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $632M | Buy |
2,368,796
+455,101
| +24% | +$123M | 0.66% | 41 |
|
|
2025
Q4 | $480M | Buy |
+1,913,695
| New | +$508M | 0.5% | 65 |
|
|
2023
Q4 | – | Sell |
-418,995
| Closed | -$84.2M | – | 750 |
|
|
2023
Q3 | $84.2M | Sell |
418,995
-215,895
| -34% | -$45.5M | 0.12% | 211 |
|
|
2023
Q2 | $132M | Buy |
634,890
+4,300
| +0.7% | +$834K | 0.18% | 174 |
|
|
2023
Q1 | $124M | Buy |
630,590
+135,058
| +27% | +$27.8M | 0.17% | 166 |
|
|
2022
Q4 | $100M | Buy |
495,532
+8,468
| +2% | +$1.66M | 0.14% | 178 |
|
|
2022
Q3 | $85.7M | Buy |
487,064
+29,447
| +6% | +$6.03M | 0.13% | 187 |
|
|
2022
Q2 | $92.2M | Buy |
457,617
+7,456
| +2% | +$1.59M | 0.13% | 190 |
|
|
2022
Q1 | $102M | Buy |
450,161
+11,346
| +3% | +$2.67M | 0.12% | 195 |
|
|
2021
Q4 | $118M | Sell |
438,815
-3,439
| -0.8% | -$851K | 0.14% | 192 |
|
|
2021
Q3 | $107M | Buy |
442,254
+12,396
| +3% | +$3.12M | 0.14% | 200 |
|
|
2021
Q2 | $102M | Sell |
429,858
-322,243
| -43% | -$73.4M | 0.13% | 204 |
|
|
2021
Q1 | $165M | Sell |
752,101
-21,758
| -3% | -$4.37M | 0.22% | 155 |
|
|
2020
Q4 | $135M | Sell |
773,859
-633,418
| -45% | -$109M | 0.21% | 158 |
|
|
2020
Q3 | $228M | Sell |
1,407,277
-369,861
| -21% | -$58.6M | 0.41% | 81 |
|
|
2020
Q2 | $254M | Sell |
1,777,138
-78,941
| -4% | -$10.9M | 0.47% | 71 |
|
|
2020
Q1 | $201M | Buy |
1,856,079
+39,386
| +2% | +$5.67M | 0.4% | 83 |
|
|
2019
Q4 | $264M | Sell |
1,816,693
-101,106
| -5% | -$14.6M | 0.35% | 95 |
|
|
2019
Q3 | $277M | Sell |
1,917,799
-917,994
| -32% | -$134M | 0.37% | 86 |
|
|
2019
Q2 | $421M | Sell |
2,835,793
-350,160
| -11% | -$48.9M | 0.55% | 55 |
|
|
2019
Q1 | $419M | Sell |
3,185,953
-619,475
| -16% | -$76.3M | 0.55% | 53 |
|
|
2018
Q4 | $413M | Sell |
3,805,428
-1,391,918
| -27% | -$186M | 0.59% | 49 |
|
|
2018
Q3 | $775M | Sell |
5,197,346
-1,400,080
| -21% | -$213M | 0.9% | 25 |
|
|
2018
Q2 | $1.02B | Sell |
6,597,426
-6,839
| -0.1% | -$1.03M | 1.22% | 11 |
|
|
2018
Q1 | $918M | Buy |
6,604,265
+476,940
| +8% | +$70.1M | 1.11% | 12 |
|
|
2017
Q4 | $840M | Buy |
6,127,325
+750,029
| +14% | +$99.1M | 0.99% | 21 |
|
|
2017
Q3 | $697M | Buy |
5,377,296
+34,103
| +0.6% | +$4.55M | 0.86% | 24 |
|
|
2017
Q2 | $708M | Buy |
5,343,193
+244,601
| +5% | +$30M | 0.9% | 23 |
|
|
2017
Q1 | $628M | Buy |
5,098,592
+166,433
| +3% | +$19.7M | 0.8% | 28 |
|
|
2016
Q4 | $544M | Buy |
4,932,159
+381,546
| +8% | +$42.4M | 0.72% | 35 |
|
|
2016
Q3 | $537M | Buy |
4,550,613
+412,246
| +10% | +$48.6M | 0.75% | 31 |
|
|
2016
Q2 | $463M | Buy |
4,138,367
+1,819,454
| +78% | +$196M | 0.67% | 40 |
|
|
2016
Q1 | $233M | Buy |
2,318,913
+127,355
| +6% | +$12.2M | 0.34% | 105 |
|
|
2015
Q4 | $233M | Buy |
2,191,558
+158,460
| +8% | +$16.3M | 0.33% | 101 |
|
|
2015
Q3 | $189M | Buy |
2,033,098
+559,440
| +38% | +$57.9M | 0.29% | 119 |
|
|
2015
Q2 | $153M | Buy |
1,473,658
+269,169
| +22% | +$28M | 0.22% | 139 |
|
|
2015
Q1 | $130M | Buy |
1,204,489
+101,683
| +9% | +$10.5M | 0.19% | 148 |
|
|
2014
Q4 | $102M | Sell |
1,102,806
-3,022,561
| -73% | -$267M | 0.15% | 156 |
|
|
2014
Q3 | $361M | Buy |
4,125,367
+615,813
| +18% | +$55.6M | 0.59% | 48 |
|
|
2014
Q2 | $309M | Buy |
3,509,554
+2,423,757
| +223% | +$210M | 0.52% | 62 |
|
|
2014
Q1 | $91.6M | Buy |
1,085,797
+817,457
| +305% | +$65.2M | 0.17% | 149 |
|
|
2013
Q4 | $21.1M | Buy |
268,340
+164,290
| +158% | +$14M | 0.04% | 274 |
|
|
2013
Q3 | $8.86M | Hold |
104,050
| – | – | 0.02% | 385 |
|
|
2013
Q2 | $8.95M | Buy |
+104,050
| New | +$8.64M | 0.02% | 365 |
|
Other funds holding LH
VCM
VPM
Boston Partners's LH Position: Q1 2026 in Review
Boston Partners increased its Labcorp (LH) stake by 24% in Q1 2026, buying an estimated $123M and bringing the position to 2,368,796 shares worth $632M. The position accounts for 0.66% of the portfolio, ranked #41.
Boston Partners first reported a position in LH in Q2 2013 and has held it in 44 quarters since. The position peaked at $1.02B in Q2 2018. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Boston Partners held 2,368,796 shares of Labcorp worth $632M as of Q1 2026.
- Boston Partners bought 455,101 Labcorp shares in Q1 2026, an estimated $123M.
- Labcorp made up 0.66% of Boston Partners's portfolio in Q1 2026, its #41 holding.
- Boston Partners first reported a position in Labcorp in Q2 2013 and has held it in 44 quarters since.
- Boston Partners's Labcorp position peaked at $1.02B in Q2 2018.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Boston Partners's 13F filing for Q1 2026, filed 11 May 2026.